| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on January 5, 2006
Accepted on February 13, 2006
Department of Pediatrics (W.C., C.A.S.), Memorial Sloan-Kettering Cancer, New York, New York 10021; Division of Pediatric Endocrinology (W.C.), New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021; Department of Pediatrics (A.C.M., P.M., L.L.R.), University of Minnesota School of Medicine, Minneapolis, Minnesota 55455; Cancer Prevention Research Program (J.W.), Fred Hutchinson Cancer Research Center, Seattle, Washington, 98104; Department of Radiation Physics (M.S.), University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030 and Department of Public Health Sciences (Y.Y.), University of Alberta, Edmonton, Alberta, Canada, T6G2G3; Department of Epidemiology and Cancer Control (L.L.R.), St. Jude Children's Research Hospital, Memphis, TN, 38105
* To whom correspondence should be addressed. E-mail: sklarc{at}mskcc.org.
Context: Defined as the loss of ovarian function within 5 yr of diagnosis, acute ovarian failure (AOF) is known to develop in a subset of survivors of pediatric and adolescent cancers. Its precise incidence is unknown and data concerning its risk factors are limited.
Objective: To determine the incidence of and patient/treatment factors associated with AOF in a large cohort of pediatric cancer survivors.
Design: Retrospective cohort study.
Setting: Multicenter study.
Patients: Female participants from the Childhood Cancer Survivor Study who were
18 yr of age were considered for inclusion. We excluded survivors who received cranial irradiation at doses > 3000 cGy, those with hypothalamic/pituitary tumors and survivors who underwent bilateral oophorectomy. Survivors who reported never menstruating or who had ceased having menses within 5 yr after their cancer diagnosis were considered to have AOF.
Main outcome: Incidence and risk factors for AOF.
Results: Of a total of 3390 eligible survivors, 215 cases (6.3%) developed AOF. Survivors with AOF were older at diagnosis, more likely to have been diagnosed with Hodgkin's lymphoma or to have received abdominal or pelvic radiotherapy than survivors without AOF. Among survivors with AOF, 116 (54%) had received
1000 cGy ovarian irradiation. In a multivariable logistic regression model, increasing doses of ovarian irradiation, exposure to procarbazine, and exposure to cyclophosphamide at ages 13-20 yr were independent risk factors for AOF.
Conclusions: AOF develops in a small subset of survivors, especially those treated with
1000 cGy ovarian radiation. These results will facilitate patient counseling and selection of candidates for newer fertility preservation techniques.
This article has been cited by other articles:
![]() |
N. S. Kadan-Lottick, I. Dinu, K. Wasilewski-Masker, S. Kaste, L. R. Meacham, A. Mahajan, M. Stovall, Y. Yasui, L. L. Robison, and C. A. Sklar Osteonecrosis in Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., June 20, 2008; 26(18): 3038 - 3045. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. COHEN Cancer Treatment and the Ovary: The Effects of Chemotherapy and Radiation Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 123 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. OKTEM and K. OKTAY Preservation of Menstrual Function in Adolescent and Young Females Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 237 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Fallat, J. Hutter, and the Committee on Bioethics, Section on Hematology/ Preservation of Fertility in Pediatric and Adolescent Patients With Cancer Pediatrics, May 1, 2008; 121(5): e1461 - e1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Chen and J. E. Manson Premature Ovarian Failure in Cancer Survivors: New Insights, Looming Concerns. J Natl Cancer Inst, July 5, 2006; 98(13): 880 - 881. [Full Text] [PDF] |
||||
![]() |
C. A. Sklar, A. C. Mertens, P. Mitby, J. Whitton, M. Stovall, C. Kasper, J. Mulder, D. Green, H. S. Nicholson, Y. Yasui, et al. Premature Menopause in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Natl Cancer Inst, July 5, 2006; 98(13): 890 - 896. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |